BioLife Solutions Inc (BLFS, Financial), a leading developer, manufacturer, and supplier of bioproduction tools and services for cell and gene therapies, has reported an insider sell according to the latest SEC filings. Chief Marketing Officer Todd Berard sold 7,508 shares of the company on March 12, 2024.
Todd Berard’s transaction was executed at an average price of $16.64 per share, resulting in a total sale amount of approximately $124,893. The insider's sale was made public through an SEC Filing.
Over the past year, the insider has sold a total of 15,829 shares of BioLife Solutions Inc and has not made any purchases of the stock. This latest transaction continues a pattern of insider sales at the company, with a total of 109 insider sells and only 4 insider buys over the past year.
The market capitalization of BioLife Solutions Inc stands at $755.151 million, with the stock trading at $16.64 on the day of the insider's recent sale.
Regarding the company's valuation, BioLife Solutions Inc has a price-to-GF-Value ratio of 0.83, indicating that the stock is modestly undervalued based on its GF Value of $20.00.
The GF Value is a proprietary intrinsic value estimate from GuruFocus, which takes into account historical trading multiples, an adjustment factor based on the company's past performance, and future business performance estimates provided by Morningstar analysts.
The insider's recent sell transaction may provide investors with insight into the company's stock valuation and insider sentiment. However, it is important to consider a wide range of factors when evaluating the potential investment in any stock.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
